1567. Pharmacokinetic/Pharmacodynamic Target Attainment in Adult and Pediatric Patients following Administration of Ceftaroline Fosamil as a 5-Minute Infusion

BACKGROUND: Ceftaroline fosamil is approved in the United States for treating patients ≥2 months old with acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia, and for similar indications in Europe. The active metabolite, ceftaroline, has in vitro activity ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccobene, Todd, ScD, T J Carrothers, Knebel, William, Raber, Susan, Chan, Phylinda L S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809530/
http://dx.doi.org/10.1093/ofid/ofz360.1431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809530/
http://dx.doi.org/10.1093/ofid/ofz360.1431

Ejemplares similares